XML 41 R25.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Stock-Based Compensation Plans | 12 Months Ended
--- | ---
Dec. 31, 2021
Share-based Payment Arrangement [Abstract] |
Stock-Based Compensation Plans | STOCK-BASED COMPENSATION PLANS On April 29, 2003 and May 1, 2012, the shareholders of the Company approved the 2003 Stock Option and Incentive Plan (“2003 Plan”) and 2012 Equity and Incentive Plan (“2012 Plan”), respectively, the maximum number of shares of stock reserved and available for issuance under the 2012 Plan was 1.2 million shares. Awards may be granted in the form of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, unrestricted stock, performance shares and dividend equivalent rights, or any combination of the preceding, and the exercise price will not be less than 100% of the fair market value on the date of grant in the case of incentive stock options, or 85% of the fair market value on the date of grant in the case of non-qualified stock options. No stock option is exercisable more than ten years after the date the stock option was granted. The exercise price of all options granted equaled the market price of the Company's stock on the date of grant, except for certain non-qualified stock options that were issued in conjunction with an acquisition. The amount of cash used to settle stock-based compensation transactions for the years ended December 31, 2021, 2020 and 2019 was $629,000, $374,000 and $455,000, respectively. Stock Option Awards Stock options granted under the 2003 Plan and the 2012 Plan include both incentive stock options and non-qualified stock options. Incentive stock options and non-qualified stock options granted vest pro-rata over a five year period, or earlier if an employee retires and has met the retirement eligibility requirements of the plan, and have a contractual life of ten years. On the date of each grant, the fair value of each award is derived using the Black-Scholes option pricing model based on assumptions made by the Company as follows: •Dividend yield is based on the dividend rate of the Company’s stock at the date of grant. •Risk-free interest rate is based on the U.S. Treasury bond rate with a term equaling the expected life of the granted options. •Expected volatility is based on the historical volatility of the Company’s stock price calculated over the expected life of the option. •Expected life represents the period of time that granted options are expected to be outstanding based on historical trends. For the years ended December 31, 2021, 2020 and 2019, the Company did not issue any stock options. At December 31, 2021 there were no options outstanding that had been granted under the 2003 Plan. Stock option expense is recognized within salaries and employee benefits on the consolidated statements of income on a straight-line basis over the vesting period. For the years ended December 31, 2021, 2020 and 2019, the expense recognized was $0, $4,000 and $7,000, respectively. The Company does not receive any tax benefit on its issuance of incentive stock options, unless upon exercise a disqualifying disposition is made. The total tax benefit to the Company upon exercise of incentive stock options for the years ended December 31, 2021, 2020 and 2019 was $23,000, $7,000, and $8,000, respectively. Additionally, for the years ended December 31, 2021, 2020 and 2019, the Company received a tax benefit upon the exercise of non-qualified stock options, of $1,000 for each year. Stock option activity for the year ended December 31, 2021 was as follows:
(Dollars in thousands, except per option data) |  | Number of Options |  | Weighted-Average Exercise Price per Option |  | Weighted-Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value
Options outstanding at January 1, 2021 |  | 10,513 |  |  | $ | 25.29 |  |  |  |  |
Granted |  | — |  |  | — |  |  |  |  |
Exercised |  | (7,113) |  |  | 24.91 |  |  |  |  |
Forfeited |  | (400) |  |  | 42.44 |  |  |  |  |
Expired |  | — |  |  | — |  |  |  |  |
Options outstanding at December 31, 2021 |  | 3,000 |  |  | $ | 23.89 |  |  | 2.5 |  | $ | 73 |
Options exercisable at December 31, 2021 |  | 3,000 |  |  | $ | 23.89 |  |  | 2.5 |  | $ | 73 |
A summary of the status of the Company’s nonvested stock options as of December 31, 2021 and changes during the year then ended was as follows:
| Options |  | Weighted-Average Grant Date Fair Value per Option
Nonvested at January 1, 2021 | 900 |  |  | $ | 6.89 |
Granted | — |  |  | — |
Vested | (500) |  |  | 6.18 |
Forfeited | (400) |  |  | 7.78 |
Nonvested at December 31, 2021 | — |  |  | $ | — |
For the years ended December 31, 2021, 2020 and 2019, the Company received cash from the exercise of stock options of $159,000, $33,000 and $95,000 respectively. The Company did not have any unrecognized expense for non-vested stock options at December 31, 2021. The total intrinsic value of options exercised for the years ended December 31, 2021, 2020 and 2019 was $146,000, $90,000, and $309,000, respectively. Restricted Stock Units Restricted stock units vest pro-rata over the requisite service period, which is typically three or five years. Restricted stock units issued do not participate in dividends and recipients are not entitled to vote these restricted units until they vest. For the years ended December 31, 2021, 2020 and 2019, the Company issued restricted stock units with a grant-date fair value of $994,000, $500,000 and $657,000, respectively, to certain employees. The grant-date fair value is calculated utilizing the Company's closing market share price as of the date the awards are granted. Restricted stock unit expense is recognized within salaries and employee benefits on the consolidated statements of income on a straight-line basis over the vesting period. The expense and the related income tax benefit recognized in connection with the restricted stock units was as follows for the periods indicated:
|  | For the Year Ended December 31,
(In thousands) |  | 2021 |  | 2020 |  | 2019
Expense |  | $ | 610 |  |  | $ | 475 |  |  | $ | 389 |
Income tax benefit |  | 131 |  |  | 102 |  |  | 84 |
Fair value of grants vested |  | 506 |  |  | 407 |  |  | 302 |
Restricted stock unit activity for the year ended December 31, 2021 was as follows:
(Dollars in thousands, except per unit data) |  | Number of Units |  | Weighted-Average Grant Date Fair Value per Unit |  | Weighted-Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value |  | Unrecognized Compensation
Nonvested at January 1, 2021 |  | 46,367 |  |  | $ | 37.80 |  |  |  |  |  |  |
Granted |  | 20,689 |  |  | 48.05 |  |  |  |  |  |  |
Vested |  | (12,818) |  |  | 39.49 |  |  |  |  |  |  |
Forfeited |  | (4,653) |  |  | 42.10 |  |  |  |  |  |  |
Nonvested at December 31, 2021 |  | 49,585 |  |  | $ | 41.23 |  |  | 3.1 |  | $ | 2,388 |  |  | $ | 1,529 |
Restricted Stock Awards Restricted stock awards vest pro-rata over the requisite service period, which is typically three years, or earlier if a recipient retires and has met the retirement eligibility requirements of the plan. Awards issued to Company directors are not subject to any service requirements and vest immediately. Nonvested restricted stock awards participate in Company dividends and recipients are entitled to vote these restricted shares during the vesting period. For the years ended December 31, 2021, 2020 and 2019, the Company issued restricted stock awards with a grant-date fair value of $924,000, $1.0 million and $724,000, respectively, to certain directors and employees. The grant-date fair value is calculated utilizing the Company's closing market share price as of the date the awards are granted. The expense for restricted stock awards issued to employees of the Company is recognized within salaries and employee benefits on the consolidated statements of income on a straight-line basis over the vesting period. The expense for awards issued to directors of the Company (which are not subject to service requirements and vest immediately) is recognized with consulting and professional fees on the consolidated statements of income. The expense and the related income tax benefit recognized in connection with the restricted stock awards was as follows for the periods indicated:
|  | For the Year Ended December 31,
(In thousands) |  | 2021 |  | 2020 |  | 2019
Expense |  | $ | 895 |  |  | $ | 781 |  |  | $ | 751 |
Income tax benefit |  | 192 |  |  | 168 |  |  | 161 |
Fair value of grants vested |  | 901 |  |  | 772 |  |  | 780 |
Restricted stock award activity, which includes awards issued to directors of the Company, for the year ended December 31, 2021 was as follows:
(Dollars in thousands, except per share data) |  | Number of Shares |  | Weighted-Average Grant Date Fair Value per Share |  | Weighted-Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value |  | Unrecognized Compensation
Nonvested at January 1, 2021 |  | 23,656 |  |  | $ | 34.96 |  |  |  |  |  |  |
Granted |  | 19,538 |  |  | 47.29 |  |  |  |  |  |  |
Vested |  | (21,706) |  |  | 41.52 |  |  |  |  |  |  |
Forfeited |  | (2,517) |  |  | 37.64 |  |  |  |  |  |  |
Nonvested at December 31, 2021 |  | 18,971 |  |  | $ | 39.80 |  |  | 1.6 |  | $ | 914 |  |  | $ | 459 |
MSPP The Company offers the MSPP to provide an opportunity for certain employees to receive restricted shares of the Company’s common stock in lieu of a portion of their annual incentive bonus. Restricted shares issued under the MSPP are granted at a discount of the fair market value of the stock on the date of grant and they cliff vest two years after the grant date, or earlier if a recipient reaches the retirement eligibility requirements of the Plan. Should an employee forfeit his or her non-vested MSPP awards, the Company will return the lesser of the strike price paid by the employee or the fair value of the non-vested awards as of the date forfeited. Restricted stock issued under the MSPP participate in Company dividends and are entitled to vote these restricted shares during the vesting period. For the years ended December 31, 2021, 2020 and 2019, the Company issued MSPP awards with a grant-date fair value of $157,000, $83,000 and $85,000, respectively, to certain employees. The expense for restricted stock awards is recognized within salaries and employee benefits on the consolidated statements of income on a straight-line basis over the vesting period. The expense and the related income tax benefit recognized in connection with the MSPP awards was as follows for the periods indicated:
|  | For the Year Ended December 31,
(In thousands) |  | 2021 |  | 2020 |  | 2019
Expense |  | $ | 104 |  |  | $ | 71 |  |  | $ | 95 |
Income tax benefit |  | 22 |  |  | 15 |  |  | 20 |
Fair value of grants vested |  | 70 |  |  | 110 |  |  | 75 |
MSPP award activity for the year ended December 31, 2021 was as follows:
(Dollars in thousands, except per share data) |  | Number of Shares |  | Weighted-Average Grant Date Fair Value per Share |  | Weighted-Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value |  | Unrecognized Compensation
Nonvested at January 1, 2021 |  | 17,024 |  |  | $ | 8.74 |  |  |  |  |  |  |
Granted |  | 9,619 |  |  | 16.35 |  |  |  |  |  |  |
Vested |  | (6,338) |  |  | 11.02 |  |  |  |  |  |  |
Forfeited |  | (1,414) |  |  | 11.46 |  |  |  |  |  |  |
Nonvested at December 31, 2021 |  | 18,891 |  |  | $ | 11.64 |  |  | 0.7 |  | $ | 356 |  |  | $ | 88 |
For the years ended December 31, 2021, 2020 and 2019, the Company received cash from the issuance of restricted shares under the MSPP of $324,000, $247,000 and $250,000, respectively. At December 31, 2021 and 2020, cash received from certain participating employees totaled $554,000 and $455,000, respectively, and was presented within accrued interest and other liabilities on the consolidated statements of condition. LTIP The LTIP is intended to attract and retain executives who will contribute to the Company’s future success. The long-term performance period is a period of three consecutive years beginning on January 1 of the first year and ending on December 31 of the third year. Awards granted are 50% weighted on the attainment of certain performance targets approved by the Board of Directors and 50% weighted on meeting the requisite service period. The performance-based share units granted will vest only if the performance targets are achieved, and the amount received by the LTIP participants may vary from 0% - 200% of target, depending on the level at which performance targets are met. Failure to achieve the specific performance measures will result in all or a portion of the performance-based share units being forfeited. The service-based awards are restricted stock awards and generally vest annually pro-rata over a three year period. The associated service-based awards are disclosed within the aforementioned “Restricted Stock Awards” section of this note. For the years ended December 31, 2021, 2020 and 2019, the Company issued performance-based stock awards with a grant-date fair value of $753,000, $978,000 and $624,000, respectively. The grant-date fair value is calculated utilizing the Company's closing market share price as of the date the awards are granted. The expense for the performance-based share units is recognized within salaries and employee benefits on the consolidated statements of income on a straight-line basis over the vesting period. The expense and the related tax benefit for the LTIP's performance-based share units was as follows for the periods indicated:
|  | For the Year Ended December 31,
(In thousands) |  | 2021 |  | 2020 |  | 2019
Expense |  | $ | 637 |  |  | $ | 332 |  |  | $ | 532 |
Related income tax benefit |  | 137 |  |  | 71 |  |  | 114 |
Fair value of grants vested |  | 435 |  |  | — |  |  | 344 |
LTIP performance-based share unit activity for the year ended December 31, 2021 was as follows:
(Dollars in thousands, except per share data) |  | Number of Shares |  | Weighted-Average Grant Date Fair Value per Share |  | Weighted-Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value |  | Unrecognized Compensation
Nonvested at January 1, 2021 |  | 51,394 |  |  | $ | 37.07 |  |  |  |  |  |  |
Granted(1) |  | 17,822 |  |  | 46.95 |  |  |  |  |  |  |
Vested |  | (10,157) |  |  | 42.82 |  |  |  |  |  |  |
Forfeited |  | (7,479) |  |  | 38.32 |  |  |  |  |  |  |
Nonvested at December 31, 2021 |  | 51,580 |  |  | $ | 39.17 |  |  | 1.6 |  | $ | 2,020 |  |  | $ | 434 |
(1) Number of shares granted assumes payout at 200% of target. DCRP The DCRP is an unfunded deferred compensation plan for the benefit of certain Company executives. Annually, participants will receive a credit to an account administered by the Company of 10% of each participant’s annual base salary and bonus for the prior performance period. Annual credits to a participant’s account will be denominated in deferred stock awards (the right to receive a share of common stock of the Company upon the satisfaction of certain restrictions) based on the fair market value of the common stock of the Company on the date of grant. For all active participants vesting occurs ratably from the date of participation until the participant reaches the age of 65, at which time the participant is 100% vested. In 2018, the DCRP was amended providing the ability to tailor vesting terms for new participants. For the years ended December 31, 2021, 2020 and 2019, the Company issued DCRP awards with a grant-date fair value of $247,000, $169,000 and $153,000, respectively. The grant-date fair value is calculated utilizing the Company's closing market share price as of the date the awards are granted. The expense for the DCRP is recognized within salaries and employee benefits on the consolidated statements of income on a straight-line basis over the vesting period. Compensation expense and the related tax benefit recognized in connection with the DCRP was as follows for the periods presented:
|  | For the Year Ended December 31,
(In thousands) |  | 2021 |  | 2020 |  | 2019
Expense |  | $ | 135 |  |  | $ | 122 |  |  | $ | 110 |
Related income tax benefit |  | 29 |  |  | 26 |  |  | 24 |
Fair value of grants vested |  | 118 |  |  | 129 |  |  | 102 |
DCRP award activity for the year ended December 31, 2021 was as follows:
(Dollars in thousands, except per award data) |  | Number of Deferred Stock Awards |  | Weighted-Average Grant Date Fair Value per Award |  | Weighted-Average Remaining Contractual Term (Years) |  | Aggregate Intrinsic Value |  | Unrecognized Compensation
Nonvested at January 1, 2021 |  | 5,372 |  |  | $ | 33.93 |  |  |  |  |  |  |
Granted |  | 5,167 |  |  | 47.75 |  |  |  |  |  |  |
Vested |  | (2,933) |  |  | 40.16 |  |  |  |  |  |  |
Forfeited |  | (600) |  |  | 47.75 |  |  |  |  |  |  |
Nonvested at December 31, 2021 |  | 7,006 |  |  | $ | 40.33 |  |  | 16.0 |  | $ | 337 |  |  | $ | 234 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration